NO991734D0 - Pyrazolinones for the treatment of potency disorders - Google Patents

Pyrazolinones for the treatment of potency disorders

Info

Publication number: NO991734D0
Authority: NO; Norway
Prior art keywords: pyrazolinones; treatment; potency disorders; potency; disorders
Prior art date: 1996-10-14

Application number

NO991734A

Other languages

Norwegian (no)

Other versions

NO991734L (en

Inventor

Michael Arlt

Rochus Jonas

Pierre Schelling

Maria Christadler

Franz-Werner Kluxen

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-14

Filing date

1999-04-13

Publication date

1999-04-13

1999-04-13 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

1999-04-13 Publication of NO991734D0 publication Critical patent/NO991734D0/en

1999-04-13 Publication of NO991734L publication Critical patent/NO991734L/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Gynecology & Obstetrics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO991734A 1996-10-14 1999-04-13 Pyrazolinones for the treatment of potency disorders NO991734L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19642284A DE19642284A1 (en)	1996-10-14	1996-10-14	Pyrazolinones for the treatment of erectile dysfunction
PCT/EP1997/005532 WO1998016224A1 (en)	1996-10-14	1997-10-08	Pyrazolinones to treat disturbances of potency

Publications (2)

Publication Number	Publication Date
NO991734D0 true NO991734D0 (en)	1999-04-13
NO991734L NO991734L (en)	1999-04-13

Family

ID=7808669

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO991734A NO991734L (en)	1996-10-14	1999-04-13	Pyrazolinones for the treatment of potency disorders

Country Status (14)

Country	Link
EP (1)	EP0930881A1 (en)
JP (1)	JP2001501958A (en)
KR (1)	KR20000049086A (en)
CN (1)	CN1233178A (en)
AR (1)	AR008494A1 (en)
AU (1)	AU4945297A (en)
BR (1)	BR9712307A (en)
CA (1)	CA2268823A1 (en)
DE (1)	DE19642284A1 (en)
HU (1)	HUP0000233A3 (en)
NO (1)	NO991734L (en)
PL (1)	PL332821A1 (en)
WO (1)	WO1998016224A1 (en)
ZA (1)	ZA979151B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6410584B1 (en)	1998-01-14	2002-06-25	Cell Pathways, Inc.	Method for inhibiting neoplastic cells with indole derivatives
US6200771B1 (en)	1998-10-15	2001-03-13	Cell Pathways, Inc.	Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
US6133271A (en) *	1998-11-19	2000-10-17	Cell Pathways, Inc.	Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
US6187779B1 (en)	1998-11-20	2001-02-13	Cell Pathways, Inc.	Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
US6369092B1 (en)	1998-11-23	2002-04-09	Cell Pathways, Inc.	Method for treating neoplasia by exposure to substituted benzimidazole derivatives
US6486155B1 (en)	1998-11-24	2002-11-26	Cell Pathways Inc	Method of inhibiting neoplastic cells with isoquinoline derivatives
US6077842A (en) *	1998-11-24	2000-06-20	Cell Pathways, Inc.	Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives
US6034099A (en) *	1998-11-24	2000-03-07	Cell Pathways, Inc.	Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones
US6875575B1 (en)	1998-11-25	2005-04-05	Osi Pharmaceuticals, Inc.	Diagnostic methods for neoplasia
US6020379A (en) *	1999-02-19	2000-02-01	Cell Pathways, Inc.	Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9301192D0 (en) *	1993-06-09	1993-06-09	Trott Francis W	Flower shaped mechanised table
DE19518082A1 (en) *	1995-05-17	1996-11-21	Merck Patent Gmbh	4 (-Arylaminomethylene) -2,4-dihydropyrazol-3-one

1996
- 1996-10-14 DE DE19642284A patent/DE19642284A1/en not_active Withdrawn
1997
- 1997-10-08 HU HU0000233A patent/HUP0000233A3/en unknown
- 1997-10-08 JP JP10517987A patent/JP2001501958A/en active Pending
- 1997-10-08 EP EP97912141A patent/EP0930881A1/en not_active Withdrawn
- 1997-10-08 CN CN97198764A patent/CN1233178A/en active Pending
- 1997-10-08 WO PCT/EP1997/005532 patent/WO1998016224A1/en not_active Application Discontinuation
- 1997-10-08 PL PL97332821A patent/PL332821A1/en unknown
- 1997-10-08 BR BR9712307-2A patent/BR9712307A/en not_active Application Discontinuation
- 1997-10-08 AU AU49452/97A patent/AU4945297A/en not_active Abandoned
- 1997-10-08 CA CA002268823A patent/CA2268823A1/en not_active Abandoned
- 1997-10-08 KR KR1019990703161A patent/KR20000049086A/en not_active Application Discontinuation
- 1997-10-13 ZA ZA9709151A patent/ZA979151B/en unknown
- 1997-10-14 AR ARP970104715A patent/AR008494A1/en unknown
1999
- 1999-04-13 NO NO991734A patent/NO991734L/en unknown

Also Published As

Publication number	Publication date
AR008494A1 (en)	2000-01-19
JP2001501958A (en)	2001-02-13
AU4945297A (en)	1998-05-11
ZA979151B (en)	1998-05-11
BR9712307A (en)	1999-08-31
DE19642284A1 (en)	1998-04-16
CN1233178A (en)	1999-10-27
CA2268823A1 (en)	1998-04-23
HUP0000233A3 (en)	2001-06-28
KR20000049086A (en)	2000-07-25
EP0930881A1 (en)	1999-07-28
PL332821A1 (en)	1999-10-11
HUP0000233A2 (en)	2001-04-28
WO1998016224A1 (en)	1998-04-23
NO991734L (en)	1999-04-13

Similar Documents

Publication	Publication Date	Title
NO986052D0 (en)	1998-12-22	Anticonvulsant derivatives for the treatment of obesity
NO991955D0 (en)	1999-04-23	Process for the treatment of hydrocarbons
NO306977B1 (en)	2000-01-24	Use of thienol [1,5] benzodiazepine for the treatment of gastrointestinal disorders
NO970153L (en)	1997-01-14	Process for the Synthesis of Substituted Sulfoxides
NO965377L (en)	1997-02-12	Indolinone compounds for the treatment of diseases
IL129998A0 (en)	2000-02-29	Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
NO20003042D0 (en)	2000-06-14	Procedure for the prophylactic treatment of mastitis
NO991459L (en)	1999-03-25	Use of 1-hydroxy-2-pyridones for the treatment of skin infections
ID27214A (en)	2001-03-08	TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS
NO991734D0 (en)	1999-04-13	Pyrazolinones for the treatment of potency disorders
NO984432D0 (en)	1998-09-23	Procedure for the treatment of migraine pain
NO996432L (en)	2000-02-09	Process for the preparation of 4-substituted-1H-indole-3-glycosamides
NO973366D0 (en)	1997-07-21	Procedure for the treatment of multiple sclerosis
NO985535L (en)	1999-01-27	Process for the preparation of 1,3-alkanediols
NO983784D0 (en)	1998-08-19	Processes for the preparation of biphenyl-isoxazole sulfonamides
NO982562D0 (en)	1998-06-04	Composition for the treatment of pain
NO20012612D0 (en)	2001-05-28	Isonipecotamides for the treatment of integrin-mediated disorders
NO991158D0 (en)	1999-03-10	Procedure for the treatment of amyotrophic lateral sclerosis
NO984189D0 (en)	1998-09-11	Procedure for the treatment of bipolar disorder
NO953089L (en)	1995-10-06	Steroids for the treatment of menopausal disorders
NO993549L (en)	1999-09-21	Imino-aza-anthracycline derivatives for the treatment of amyloidosis
NO952411D0 (en)	1995-06-16	Means for the treatment of metabolic bone disorders
NO986053D0 (en)	1998-12-22	Anticonvulsant derivatives for the treatment of psoriasis
NO20003077L (en)	2000-06-15	Process for the preparation of the chlorobenzoxazole
NO962812D0 (en)	1996-07-03	Procedure for the treatment of pneumonia